<DOC>
	<DOCNO>NCT02089490</DOCNO>
	<brief_summary>The dermal substitute NEVELIA® receive CE mark July 9 , 2013 . Its use NEVAL protocol accordance leaflet , i.e . treatment burn case reconstructive plastic surgery . The matric implantation follow autologous skin graft neodermis formation observe .</brief_summary>
	<brief_title>Evaluation NEVELIA® Terms Safety Efficacy Third-degree Burns Treatment Reconstructive Surgery</brief_title>
	<detailed_description>The NEVAL protocol descriptive study conduct order confirm clinical evidence safety performance NEVELIA® , describe literature equivalent product . This dermal substitute consist inner biodegradable dermal substitute make bovine collagen ( collagen type I ) , cover outer silicone membrane . Its porosity speed degradation allow act recolonization fibroblasts initiation vascularization process within 3 week . The application procedure require removement silicone layer wound cover ultra-thin epidermal graft , possibly mesh . This surgical procedure well-known permit ultra-thin epidermal graft . All patient treat NEVELIA® , prior autologous skin graft within 3 week application . Then , three follow-up visit plan : post operatively , 6 12 month . The objective : - Primary objective : To assess type frequency complication - Secondary objective : - To assess take rate NEVELIA® - To assess take rate skin graft - To assess satisfaction rate physician patient , - To assess quality heal skin , - To assess rate re-operation 12 month .</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>Patients age 18 old Patient geographically stable , Patient require dermal reconstruction thirddegree burn , reconstructive surgery trauma surgery ; Patient sign nonopposition form ; Patient able follow 12 month . Patient clinical sign wound infection ; Allergic patient know allergy bovine collagen silicone ; Patient lifethreatening condition ; Patient receive treatment may affect wound heal ; Patient autoimmune immunosuppressive disease ; Patient suspect neurological disease CreutzfeldtJakob disease ; Patient simultaneously participate another study ; Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>